Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
Clinical trial NCT00116142 · COMPLETED
Trial details
- NCT number
- NCT00116142
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2020-06-29
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.